Регистрация | Вход в службу | FAQ      [?] 

Ключевое слово depression [733 articles]

Recent papers classified by the tag depression.
  • Serotonin transporter modulation in blood lymphocytes from patients with major depression.
    Cellular and molecular neurobiology, Vol. 22, No. 5-6. (December 2002), pp. 797-804.
    by L Lima, M Urbina
    posted to sert lymphocyte depression by yogesh9ic on 2008-09-02 22:29:57 as *****
  • Serotonin transporter is differentially localized in subpopulations of lymphocytes of major depression patients. Effect of fluoxetine on proliferation.
    Journal of neuroimmunology, Vol. 196, No. 1-2. (30 May 2008), pp. 173-180.
    by F Fazzino, C Montes, M Urbina, I Carreira, L Lima
    posted to sert lymphocyte depression by yogesh9ic on 2008-09-04 20:18:44 as ***
  • Noradrenaline transporter and its turnover rate are decreased in blood lymphocytes of patients with major depression.
    Journal of neuroimmunology, Vol. 170, No. 1-2. (30 December 2005), pp. 134-140.
    by S Mata, M Urbina, E Manzano, T Ortiz, L Lima
    posted to net lymphocyte depression by yogesh9ic on 2008-09-04 20:08:08 as ***
  • [3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine.
    International journal of immunopharmacology, Vol. 21, No. 10. (October 1999), pp. 631-646.
    by M Urbina, S Pineda, L Piñango, I Carreira, L Lima
    posted to sert lymphocyte fluoxetine depression by yogesh9ic on 2008-09-04 17:04:56 as ***
  • Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus.
    Biol Psychiatry (6 January 2007)
    by Michael D D Greicius, Benjamin H H Flores, Vinod Menon, Gary H H Glover, Hugh B B Solvason, Heather Kenna, Allan L L Reiss, Alan F F Schatzberg
    posted to default-mode depression ica resting-state by xinian on 2007-01-26 10:02:07 as read along with 4 people and 1 group pbellec pervane prerona suizan resting-state_networks
  • Mood stabilizers, glycogen synthase kinase-3beta and cell survival.
    Mol Psychiatry, Vol. 7 Suppl 1 (2002)
    by RS Jope, GN Bijur
    posted to anti-depressant bipolar depression disorder drug glycogen gsk-3-beta kinase-3-beta lithium mania mood psychiatry psychosis stabilizer synthase by xico on 2007-07-06 17:22:20 as ** along with 1 group WetBiology
  • WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
    Cochrane Database Syst Rev, No. 3. (2007)
    by JR Geddes, N Freemantle, J Mason, MP Eccles, J Boynton
    posted to as depression by worx11 on 2007-10-18 13:29:29 as ** along with 1 group XROWXR
  • Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.
    J Clin Psychiatry, Vol. 67, No. 12. (December 2006), pp. 1836-1855.
    by HG Ruhé, J Huyser, JA Swinkels, AH Schene
    posted to as depression by worx11 on 2007-10-18 13:28:12 as ** along with 1 person and 3 groups vdbroekw Neuroscience Psychiatry XROWXR
  • An overview of SSRI and SNRI therapies for depression.
    Manag Care, Vol. 13, No. 6 Suppl Depression. (June 2004), pp. 25-33.
    by JB Weilburg
    posted to as depression by worx11 on 2007-10-18 13:28:33 as ** along with 1 group XROWXR
  • Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.
    Ann Intern Med, Vol. 143, No. 6. (20 September 2005), pp. 415-426.
    by RA Hansen, G Gartlehner, KN Lohr, BN Gaynes, TS Carey
    posted to ahrq as depression by worx11 on 2007-08-21 19:56:20 as ** along with 1 group XROWXR
  • Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation
    International Journal of Clinical Practice, Vol. 61, No. 4. (April 2007), pp. 702-710.
    by Llorca, , Fernandez, -L
    posted to as depression by worx11 on 2007-08-21 20:04:59 as ** along with 1 group XROWXR
  • Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Clin Drug Investig, Vol. 27, No. 7. (2007), pp. 481-492.
    by A Khan, A Bose, GS Alexopoulos, C Gommoll, D Li, C Gandhi
    posted to ahrq as depression by worx11 on 2007-08-21 19:37:12 as ** along with 1 group XROWXR
  • Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany.
    Eur J Health Econ, Vol. 6, No. 4. (December 2005), pp. 317-321.
    by W Kulp, JM von der Schulenburg, W Greiner
    posted to as depression by worx11 on 2007-08-22 17:08:41 as ** along with 1 group XROWXR
  • Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder
    Current Medical Research and Opinion, Vol. 23, No. 6. (June 2007), pp. 1303-1318.
    by Pigott, A Teresa, Prakash, Apurva, Arnold, M Lesley, Aaronson, T Scott, Mallinckrodt, H Craig, Wohlreich, M Madelaine
    posted to ahrq as depression by worx11 on 2007-08-21 19:49:16 as ** along with 1 group XROWXR
  • Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder
    Current Medical Research and Opinion, Vol. 23, No. 2. (February 2007), pp. 251-258.
    by Armstrong, P Edward, Skrepnek, H Grant, Haim Erder,
    posted to as depression by worx11 on 2007-08-22 17:50:54 as ** along with 1 group XROWXR
  • SSRIs versus other antidepressants for depressive disorder.
    Cochrane Database Syst Rev, No. 2. (2000)
    by JR Geddes, N Freemantle, J Mason, MP Eccles, J Boynton
    posted to as depression by worx11 on 2007-10-18 13:30:13 as ** along with 1 group XROWXR
  • A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium
    Clinical Therapeutics, Vol. 27, No. 1. (January 2005), pp. 111-124.
    by Koen Demyttenaere, Michiel E Hemels, Joumana Hudry, Lieven Annemans
    posted to as depression by worx11 on 2007-08-22 17:05:44 as ** along with 1 group XROWXR
  • WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Cochrane Database Syst Rev, No. 3. (2007)
    by C Barbui, M Hotopf, N Freemantle, J Boynton, R Churchill, MP Eccles, JR Geddes, R Hardy, G Lewis, JM Mason
    posted to as depression by worx11 on 2007-10-18 13:29:50 as ** along with 1 group XROWXR
  • Evidence based review of escitalopram in treating major depressive disorder in primary care.
    Int Clin Psychopharmacol, Vol. 19, No. 5. (September 2004), pp. 305-310.
    by TR Einarson
    posted to as depression by worx11 on 2007-08-21 20:00:43 as ** along with 1 group XROWXR
  • Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents.
    Biol Psychiatry (21 June 2007)
    by George I I Papakostas, Michael E E Thase, Maurizio Fava, J Craig Nelson, Richard C C Shelton
    posted to as depression by worx11 on 2007-08-21 20:20:58 as ** along with 1 group XROWXR
  • Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
    Int Clin Psychopharmacol, Vol. 22, No. 2. (March 2007), pp. 107-115.
    by B Fantino, N Moore, H Verdoux, JP Auray
    posted to as depression by worx11 on 2007-10-18 17:22:13 as ** along with 1 group XROWXR
  • Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan
    Journal of Clinical Pharmacy & Therapeutics, Vol. 32, No. 4. (August 2007), pp. 353-363.
    by Wu, -S, Chen, -C, Lu, -B
    posted to as depression by worx11 on 2007-08-22 17:45:43 as ** along with 1 group XROWXR
  • Discontinuation symptoms in depression and anxiety disorders.
    Int J Neuropsychopharmacol (19 December 2005), pp. 1-12.
    by David S S Baldwin, Stuart A A Montgomery, Rico Nil, Malcolm Lader
    posted to as depression by worx11 on 2007-08-21 20:25:18 as ** along with 1 person and 1 group torfis XROWXR
  • A budget-impact and cost-effectiveness model for second-line treatment of major depression.
    J Manag Care Pharm, Vol. 13, No. 6. (g 2007), pp. 8-18.
    by DC Malone
    posted to as depression by worx11 on 2007-08-22 16:07:51 as ** along with 1 group XROWXR
  • A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder
    Current Medical Research and Opinion, Vol. 23, No. 7. (July 2007), pp. 1605-1614.
    by Wade, , Gembert, , Florea,
    posted to ahrq as depression by worx11 on 2007-08-21 19:44:13 as ** along with 1 group XROWXR
  • Evidence of cost-effective treatments for depression: a systematic review.
    J Affect Disord, Vol. 84, No. 1. (January 2005), pp. 1-13.
    by B Barrett, S Byford, M Knapp
    posted to as depression by worx11 on 2007-08-22 16:07:06 as ** along with 1 group XROWXR
  • Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women.
    Arch Gen Psychiatry, Vol. 62, No. 8. (August 2005), pp. 868-875.
    by DA Revicki, J Siddique, L Frank, JY Chung, BL Green, J Krupnick, M Prasad, J Miranda
    posted to as depression by worx11 on 2007-08-22 17:12:39 as ** along with 1 group XROWXR
  • A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom
    Clinical Therapeutics, Vol. 27, No. 4. (April 2005), pp. 486-496.
    by Alan G Wade, Idris Toumi, Michiel E Hemels
    posted to as depression by worx11 on 2007-08-22 16:54:52 as ** along with 1 group XROWXR
  • Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder.
    Pharmacoeconomics, Vol. 23, No. 2. (2005), pp. 155-167.
    by JL Fernandez, S Montgomery, C Francois
    posted to as depression by worx11 on 2007-08-22 17:12:14 as ** along with 1 group XROWXR
  • [Review of double-blind studies comparing SSRI and SNRI]
    Seishin Shinkeigaku Zasshi, Vol. 106, No. 10. (2004), pp. 1203-1217.
    by E Suzuki, S Maruta
    posted to as depression by worx11 on 2007-10-18 13:29:01 as ** along with 1 group XROWXR
  • notes Effects of pain on functioning and well-being in older adults with osteoarthritis of the knee.
    Psychol Aging, Vol. 18, No. 4. (December 2003), pp. 844-850.
    by J Bookwala, TL Harralson, PA Parmelee
    posted to adults depression elderly older osteoarthritis perceptions social by willwade on 2005-05-04 19:59:34 as ** along with 2 groups AssistiveTechnology PostureMobility
  • Steroids and depression
    BMJ, Vol. 316, No. 7127. (24 January 1998), pp. 244-245.
    by Alexander Mitchell, Veronica O'Keane
    posted to cs3 depression by willwade on 2005-10-28 12:07:15 as **** along with 2 groups AssistiveTechnology PostureMobility
  • Panic attacks, depression and anxiety symptoms, and substance use behaviors during late adolescence.
    J Anxiety Disord, Vol. 18, No. 5. (2004), pp. 573-585.
    by DP Valentiner, NS Mounts, BJ Deacon
    posted to bipolar case-study depression pp3 susbtance-abuse by willwade on 2005-10-24 23:06:40 as ** along with 2 groups AssistiveTechnology PostureMobility
  • notes Postpartum major depression: detection and treatment.
    Am Fam Physician, Vol. 59, No. 8. (15 April 1999)
    by CN Epperson
    posted to case-study depression postpartum pp3 by willwade on 2005-10-20 22:34:09 as ** along with 2 groups AssistiveTechnology PostureMobility
  • Cortisol reactivity and anxiety and depression in pregnant adolescents: a longitudinal perspective.
    Psychoneuroendocrinology, Vol. 18, No. 3. (1993), pp. 219-239.
    by LD Dorn, EJ Susman, AC Petersen
    posted to case-study depression pp3 prepartum by willwade on 2005-10-23 14:25:13 as ** along with 2 groups AssistiveTechnology PostureMobility
  • Anxiety & Depression Workbook For Dummies (For Dummies (Psychology & Self Help))
    (07 November 2005)
    by Charles, Laura, Aaron
    posted to workbook dummies depression book anxiety by willwade on 2008-10-11 10:34:44 as **
  • Treating patients with bipolar disorder and substance dependence: lessons learned.
    J Subst Abuse Treat, Vol. 27, No. 4. (December 2004), pp. 307-312.
    by RD Weiss
    posted to bipolar case-study depression pp3 susbtance-abuse by willwade on 2005-10-24 23:06:36 as ** along with 2 groups AssistiveTechnology PostureMobility
  • Genetic and environmental influences on the relationships between family connectedness, school connectedness, and adolescent depressed mood: sex differences.
    Dev Psychol, Vol. 35, No. 4. (July 1999), pp. 926-939.
    by KC Jacobson, DC Rowe
    posted to cs3 depression genetics by willwade on 2005-11-09 17:16:27 as ** along with 2 groups AssistiveTechnology PostureMobility
  • Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression
    Cost Effectiveness and Resource Allocation, Vol. 4 (23 October 2006), 18.
    by Trong K Le, Stephen L Able, Maureen J Lage
    posted to depression diabetes glipizide by wilco001 on 2007-06-01 21:15:18 as **
  • Behavioral activation treatments of depression: A meta-analysis
    Clinical Psychology Review, Vol. 27, No. 3. (April 2007), pp. 318-326.
    by Pim Cuijpers, Annemieke van Straten, Lisanne Warmerdam
    posted to activation depression review by vdbroekw on 2007-07-09 10:05:54 as ** along with 1 person and 4 groups kaniko Neuroscience STS Psychiatry feminist_technoscience
  • Cytokine, sickness behavior, and depression.
    Neurol Clin, Vol. 24, No. 3. (August 2006), pp. 441-460.
    by R Dantzer
    posted to sickness fatigue depression cytokine behavior by vdbroekw on 2007-01-17 09:24:55 as ** along with 2 groups Neuroscience Psychiatry
  • Animal models of mood disorders: Recent developments.
    Curr Opin Psychiatry, Vol. 20, No. 1. (January 2007), pp. 1-7.
    by JF Cryan, DA Slattery
    posted to animal depression model mouse by vdbroekw on 2007-05-09 07:27:17 as ** along with 2 groups Neuroscience Psychiatry
  • Depression in neurological disorders: an update.
    Curr Opin Psychiatry, Vol. 19, No. 3. (May 2006), pp. 294-298.
    by H Rickards
    posted to depression disease neurology parkinsons wiki by vdbroekw on 2007-05-22 12:48:25 as ** along with 2 groups Neuroscience Psychiatry
  • Adolescence: Vulnerable Period for Stress-Induced Prefrontal Cortical Function? Introduction to Part IV
    Annals of the New York Academy of Sciences, Vol. 1021, No. 1. (2004), pp. 143-147.
    by Amy F Arnsten, Rebecca M Shansky
    posted to adolescence adolescent depression by vdbroekw on 2007-07-17 22:12:18 as ** along with 2 groups Neuroscience Psychiatry
  • Pubertal hormones organize the adolescent brain and behavior
    Frontiers in Neuroendocrinology, Vol. 26, No. 3-4. ( 2005), pp. 163-174.
    by Cheryl L Sisk, Julia L Zehr
    posted to adolescence adolescent depression by vdbroekw on 2007-07-17 22:21:09 as ** along with 1 person and 2 groups suizan Neuroscience Psychiatry
  • Depression in Parkinson's disease a review
    Acta Neurologica Scandinavica, Vol. 113, No. 1. (January 2006), pp. 1-8.
    by A Lieberman
    posted to depression disease neurology parkinsons wiki by vdbroekw on 2007-05-22 12:49:10 as ** along with 2 groups Neuroscience Psychiatry
  • notes Repetitive Transcranial Magnetic Stimulation Versus Electroconvulsive Therapy: Efficacy of Treatment in Nonpsychotic Patients With Depression
    Am J Psychiatry, Vol. 164, No. 7. (1 July 2007), 1118.
    by Philip G Janicak, Sheila Dowd, Jeffrey Rado, Mary JANE Welch, Louis Fogg, Johnny O'Reardon, David Avery, Edward C Coffey, Shirlene Sampson, Nash Boutros
    posted to depression ect electroconvulsive electroshock magnetic stimulation therapy transcranial by vdbroekw on 2007-07-03 07:39:20 as ** along with 2 groups Neuroscience Psychiatry
  • Amygdala and hippocampus volumes in pediatric major depression
    Biological Psychiatry, Vol. 57, No. 1. (1 January 2005), pp. 21-26.
    by Isabelle M Rosso, Christina M Cintron, Ronald J Steingard, Perry F Renshaw, Ashley D Young, Deborah A Yurgelun-Todd
    posted to adolescents amygdala depression hippocampus by vdbroekw on 2007-07-18 13:19:36 as ** along with 1 person and 2 groups cpeysermd Neuroscience Psychiatry
  • Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
    Arch Gen Psychiatry, Vol. 63, No. 12. (December 2006), pp. 1337-1344.
    by CH Kellner, RG Knapp, G Petrides, TA Rummans, MM Husain, K Rasmussen, M Mueller, HJ Bernstein, K O'Connor, G Smith, M Biggs, SH Bailine, C Malur, E Yim, S McClintock, S Sampson, M Fink
    posted to treatment ect depression continuation antidepressants by vdbroekw on 2007-01-17 09:15:39 as ***** along with 2 groups Neuroscience Psychiatry
  • The concept of recovery in major depression.
    Psychol Med, Vol. 37, No. 3. (March 2007), pp. 307-317.
    by GA Fava, C Ruini, C Belaise
    posted to antidepressants depressiom depression efficacy review by vdbroekw on 2007-05-09 07:24:21 as ** along with 2 people and 2 groups erinem suizan Neuroscience Psychiatry
    • Вы можете ссылаться на эту страницу по адресу: http://www.citeulike.org/tag/depression

    Result page: 1 2 3 4 5 6 7 8 9 10 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.